Background/Aims: Parkinson's disease (PD) is a prevalent disease that leads to motor and cognitive disabilities, and oxidative stress (OS) injury was found to be related to the etiology of PD. Increasing evidence has shown that SHC3 is aberrantly expressed in neurons. The current study examines the involvement of SHC3 silencing in OS injury in the nigral dopamine neurons in rats with PD via the PI3K-AKT-FoxO signaling pathway. Methods: To study the mechanisms and functions of SHC3 silencing in PD at the tissue level, 170 rats were selected, and a lentivirus-based packaging system was designed to silence SHC3 expression in rats. Furthermore, PC12 cells were selected for in vitro experimentation. To evaluate the effect of SHC3 silencing in nigral dopamine neuronal growth, an MTT assay, propidium iodide (PI) single staining and Annexin V-PI double staining were performed to detect cell viability, cell cycle progression and cell apoptosis, respectively. Results: SHC3 shRNA led to decreased SOD and MDA levels and enhanced GSH activity, indicating that SHC3 silencing leads to motor retardation. SHC3 silencing repressed the extent of Akt and FoxO phosphorylation, thereby inhibiting the PI3K-AKT-FoxO signaling pathway. Furthermore, in cell experiments, SHC3 silencing suppressed PC12 cell proliferation and cell cycle progression, whereas it enhanced cell apoptosis. Conclusion: The current study provides evidence suggesting that SHC3 silencing may aggravate OS injury in nigral dopamine neurons via downregulation of the PI3K-AKT-FoxO signaling pathway in PD rats.
Parkinson's disease (PD) is characterized by gradual degeneration of the central nervous system due to loss of dopamine in brain cells and is commonly manifested as a movement disorder [1, 2] . PD is the second most widespread neurodegenerative disease and impacts approximately 2% of the population over 65 years old worldwide [3] . Chronic increased levels of reactive oxygen species (ROS) or a decreased capacity for the elimination of ROS has been called oxidative stress (OS) [4] . In addition, OS plays a significant role in the degeneration of dopamine neurons in PD [5] and is one of the mechanisms proposed to be responsible for dopamine neuron death in PD [6] . At present, no effective and restorative treatments are available to delay the neurodegenerative process of PD, and only symptomatic treatments are available on the market [7] . Therefore, modifying the disease course through neuroprotective therapy is a significant clinical need, and in this regard, the cellular mechanisms involved in the particularly vulnerable nigral neurons have been the object of intensive investigation [8, 9] .
Src homology and collagen (SHC) proteins, including SHCA, SHCB, SHCC (SHC3), SHCD, and various splice isoforms, are prototypical signaling mediators existing in mammalian cells [10] . Among these, SHC3 has been shown to be limited to neuronal cells [11] and is typically expressed in mature neurons at high levels [12] . As a signal transduction cascade, the phosphoinositide 3-kinase (PI3K) signaling pathway is vital to physiological functions such as cell survival and cell cycle, protein synthesis and growth, motility and metabolism [13] . Evidently, as a threonine/serine protein kinase, protein kinase B (AKT) was found to mediate the PI3K signaling pathway [14] . The forkhead box O (FoxO) transcription factors are some of the most conserved targets of AKT and play important roles in a number of physiological processes, such as metabolism regulation, cell cycle and response to stress factors [15] . Previous evidence demonstrated that activation of the PI3K-AKT signaling pathway is correlated with rat pheochromocytoma 12 (PC12) cells hypoxia-dependent protection [16] . A previous study demonstrated that fasudil antagonized dopamine neuronal loss and inhibited inflammation in PD mice by activating the PI3K/p-AKT signaling pathway [17] . Interestingly, it was demonstrated that treatment with γT3 and δT3 in a cellular PD model led to obvious activation of the PI3K-AKT signaling pathway [18] . Moreover, SHC3 has been shown to be involved in the inactivation of the P13K-AKT signaling pathway [12] , and via interaction with AKT, SHC proteins can contribute to OS [10, 19] . Currently, the association between SHC3 and the P13K-AKT-FoxO signaling pathway in PD remains to be explored. Therefore, the current study aims to explore the effects of SHC3 on OS injury in nigral dopamine neurons through the PI3K-AKT-FoxO signaling pathway in PD rats.
Materials and Methods

Ethical statement
The current study was carried out in accordance with the Guide for the Care and Use of Laboratory Animals issued by the US National Institutes of Health (NIH). All efforts were made to minimize the suffering of the animals included in the study.
Lentiviral vector construction and model establishment
The shRNA (5'-CACCGCTTGCCACATTCTGGAATTCAAGAGATTCCAGAATGTGGC-3', 5'-AAGCAAAAGCTTGCCACATTCTGGAATCTCTTGAATTCCAGAATGTGGCAAGC-3') and negative control (NC) shRNA (5'-CACCGTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAA-3', 5'-AAAATTCTCCGAACGTGTCACGTTCTCTTGAAACGTGACACGTTCGGAGAAC-3') sequences were designed and synthesized according to the confirmed effective siRNA target sequence and NC sequence. Target shRNA and NC shRNA were cloned into PLL3.7 vectors (Miaolingbio Inc., Wuhan, Hubei, China). Lentivirus-targeted SHC3 was obtained by cotransfection of recombinant plasmids and a packaging plasmid (pRSVrev, pMDLgpRRE, and VSV-G) into PC12 cells.
A total of 170 clean male Sprague-Dawley (SD) rats (7 weeks old; weighing 220~250 g) (purchased from the Center for Animal Experiments at Wuhan University, Wuhan, Hubei, China) were included in the study. The rats were housed with free access to food and water in a quiet environment following a 12-h light-dark cycle. The rats were randomly divided and categorized into the blank group (20 rats), the model group (50 rats), the shRNA group (50 rats) and the NC group (50 rats). No operations were conducted on the rats in the blank group, and the same doses of phosphate-buffered saline (PBS), SHC3 shRNA lentivirus, and SHC3 NC lentivirus were injected into the substantia nigra of the rats in the model, shRNA and NC groups, respectively, using a stereotaxic technique. A week following the injections, the rats were injected with 8 μg of 6-hydroxydopamine (6-OHDA) (dissolved in normal saline containing 0.2% ascorbic acid at 4 g/L) (Sigma, St. Louis, MO, USA) for the establishment of the PD model. The rats were injected with 80 mg/kg ketamine in the abdominal cavity for anesthetization and fixed on a stereotaxic apparatus (51600, Stoelting, Wood Dale, IL, USA). The exposed skin was cleaned with alcohol swabs for disinfection. According to the Rat Brain in Stereotaxic Coordinates by Paxinos and Watson, 2 μL of lentivirus, PBS and 6-OHDA were injected at the location of A/P + 1.0, L/M + 2.7, and D/V -4.0 at a rate of 1 μL/min [20] . The needle was gently extracted 10 min after injection. The rat scalps were then sutured and administered thermal insulation measures. After revival and complete recovery to normal movement, rats were rehoused in the cages. Rats in each group were injected one time with apomorphine (0.5 mg/kg) (Sigma, St. Louis, MO, USA) into the abdominal cavity 4 weeks after administration of 6-OHDA injections. Over the following 4 weeks, the rats were observed at fixed time intervals each week to record the frequency of 360° spinning per min over a 15-min period. The model was regarded as successfully established if the rats invariably spun counterclockwise at over 7 circles/min. The success rates of model establishment of the blank, shRNA and NC groups were 64% (32/50), 60% (30/50), and 62% (31/50), respectively.
Behavioral observation
After model establishment, the motor coordination of rats in each group was measured with a Rotarod experiment. A day prior to measurement, the rats were trained on a roller (diameter: 30 mm) three times at 1-h intervals. After 24 h, rats maintained balance and started moving on the roller, and the rotation rate was gradually increased from 4 rpm to 32 rpm within 5 min. After adaptation five times, time spent on the roller before falling down was regarded as the duration time and was recorded 5 times at 1-min intervals to obtain the mean value.
Rats included in the study underwent the pole-climbing test using the Ogawa method [21] . A straight wooden pole (60 cm in height, 0.18 cm in diameter) with a small wooden ball on the top was prepared. The pole was covered with gauze in case any rats slipped down. The rats were placed on the top of the pole with their heads facing upward. The duration of time that the rats needed to move from the top to the bottom of the pole was recorded five times at one-min intervals in order to obtain the mean value.
Tyrosine hydroxylase (TH) immunohistochemistry
Four weeks after successful model establishment, 10 rats in each group were randomly selected and injected with pentobarbital in the abdominal cavity for anesthetization. The hearts of the rats were perfused and fixed with 4% paraformaldehyde, and the midbrain tissue sections were extracted for TH staining. The midbrain sections were dewaxed with xylene and dehydrated with gradient ethanol solutions, followed by antigen retrieval with sodium citrate and water-proof heating for 20 min. The sections were rinsed with PBS containing 0.1% Triton X-100 for 5 min, 3% H 2 O 2 was added, and the sections were incubated at room temperature for 15 min. Next, the sections were rinsed with PBS three times, blocking serum was added, and the sections were incubated at room temperature for another 15 min. Subsequently, the sections were incubated at 4°C overnight with the TH antibody (dilution ratio of 1 : 1000, rabbit polyclonal, Abcam, Cambridge, MA, USA), and rinsed with PBS three times (3 min each). Next, biotin-labeled goat anti-rabbit immunoglobulin G (IgG) secondary antibody (dilution ratio of 1 : 200, ETI, USA) and streptomycin-labeled anti-biotin working solution (ETI, USA) were added to the sections to incubate for 30 min. Later, the sections were developed with diaminobenzidine (DAB) (Zsbio, Beijing, China), stained with hematoxylin, dehydrated with gradient ethanol, cleaned with xylene, and mounted with neutral balsam. Five sections of the substantia nigra in the midbrain near the injection position of each rat were selected in order to count the number of dark brown-stained TH-positive nigral cells under optical microscopy (magnified at 400 ×). The mean value was adopted for the final result.
Cell culture
The rat neuronal PC12 cell line (Nanjing Hwatao BioPharm Co., Ltd., Jiangsu, China) was cultured in a 5% CO 2 incubator at 37°C with Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum (FBS) (Hangzhou Sijiqing Bioengineering Material Co., Ltd., Hangzhou, China) and 5% horse serum with 1% double antibiotic (100 μg/mL streptomycin and 100 U/mL penicillin, both from Gibco, Grand Island, NY, USA). The medium was refreshed every 2~3 d, and cell passaging was conducted as cells reached 80% confluence. Cells in the logarithmic phase of growth were selected for further experimentation.
Cell transfection and grouping PC12 cells in the logarithmic phase of growth were seeded in a 6-well plate (1.8 mL in each well). The medium was replaced by antibiotic-free medium 24 h later and refreshed with serum-free medium as the cells reached 40 -60% confluence. Three pairs of siRNA (siRNA1, siRNA2, and siRNA3) and one pair of NC siRNA (Table 1) were designed and synthesized by Sangon Biological Engineering Technology & Services Co., Ltd. (Shanghai, China) according to the rat SHC3 gene. Next, the cells were transfected with siRNA in accordance with the instructions for Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Fortyeight h after transfection, the inhibitory effect of siRNA on the expression of SHC3 was determined using reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. The siRNA exhibiting the highest inhibitory efficiency was selected for further experimentation. Subsequently, the cells were assigned into the following groups: the blank group (under regular culture), the model group (100 μL of 6-OHDA was added to a final concentration of 50 g/L for PD model establishment), the siRNA 1~3 groups (100 μL of 6-OHDA was added, and cells were transfected with SHC3 siRNA/siRNA2/siRNA3) and the NC group (100 μL of 6-OHDA was added, and cells were transfected with NC siRNA).
3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay
PC12 cells were seeded in a 96-well plate at a density of 1 × 10 4 cells/well. Twelve h later, the medium was replaced, and the cells were cultured in serum-free medium for 24 h. In addition, 5 duplicates of each well were prepared. As the cells reached 50% confluence, 20 μL of MTT solution (5 g/L, Sigma, St. Louis, MO, USA) was added into each well at 6 h, 12 h, and 24 h time intervals after transfection. After a 4-h incubation at 37°C, the medium was removed, and culture was terminated. Subsequently, 100 μL of formazan solution was added to the cells in each well, which were then incubated at 37°C for 4 h to sufficiently resolve the crystalline substance. The blank group was regarded as the control, and the optical density (OD) value (A490) of each well was determined using an ELISA reader (DG5031, Shanghai Kehua Instrumentation Co., Ltd., Shanghai, China). The results were recorded in order to calculate cell viability. The cell viability was expressed as (OD value of the control group -OD value of the experiment group) / OD value (A490) of the control group × 100%. The experiment was repeated three times in order to obtain the mean value. cells/well and 2 mL/well. After culturing for 24 h, the cells were transfected with different treatments upon reaching 70%~80% confluence. Six h after transfection, the medium was refreshed, and cells were digested (not excessively) with ethylene diamine tetraacetic acid (EDTA)-free trypsin and collected for further use. Next, the cells were centrifuged at 2500 rpm/min for 5 min, rinsed with PBS two times, recentrifuged and collected. Then, the cells were fixed with 3 mL of 70% ethanol and incubated at 4°C overnight. The following day, the cells were centrifuged, the supernatant was discarded, PI staining reagent was added to the cells, and the cells were filtered through a cell filter finally. Subsequently, stained cells were analyzed using a flow cytometer (FACS Calibur, BD Biosciences, San Jose, CA, USA) at a wavelength > 575 nm for PI detection, and the percentages of cells present in different phases of the cell cycle were calculated and recorded.
Annexin V/PI double staining
Cell apoptosis in each group was evaluated according to the instructions of the Annexin V-fluorescein isothiocyanate (FITC)/PI double staining reagent kit (556547, Shanghai Solja Technology Co., Ltd., Shanghai, China). The 10 × binding buffer was diluted to 1 × binding buffer with deionized water. PC12 cells in each group were centrifuged at 2000 rpm for 5 min, collected, resuspended with precooled PBS, centrifuged at 2000 rpm for 5~10 min, and washed. The cell suspension was added to 300 µL of 1 × binding buffer, mixed with 5 µL of Annexin V-FITC, and cultured at room temperature for 15 min in dark conditions. Next, 5 µL of PI was added to the cells, bathed in ice for 5 min, and immediately after, flow cytometry (Cube6, Partec, Germany) was carried out to evaluate cell apoptosis using 488 nm excitation and 530 nm bandpass filter for FITC detection and a wavelength over 575 nm for PI detection.
RT-qPCR
Total RNA was extracted from the PC12 cells in each group using Trizol Reagent (Takara, Kusatsu, Shiga, Japan). The extracted RNA was reverse transcribed into cDNA using a reverse transcription reagent kit (Takara, Dalian, Liaoning). The primer sequences are shown in Table 2 . RT-qPCR was performed using a SYBR Premix Ex Taq II reagent kit (Takara, Kusatsu, Shiga, Japan) and an ABI 7500 qPCR instrument (Advanced Biotechnologies Inc., Suwanee, GA, USA). The reaction conditions were as follows: predenaturation at 94°C for 5 min, and 30 cycles of denaturation at 94°C for 1 min, annealing at 58°C for 1 min, and extension at 72°C for 1 min. The 20 µL reaction system was composed of the following: 10 µL of SYBR Premix Ex Taq TM II, 0.8 µL of PCR forward primer (10 µM), 0.8 µL of PCR reverse primer (10 µM), 0.4 µL of 6-carboxy-X-rhodamine (ROX) reference dye, 2.0 of µL cDNA, and 6.0 µL of sterilized distilled water. β-actin was used as the internal reference, and the relative expression of the genes was determined using the 2 -ΔCt method. The experiment was repeated three times in order to obtain the mean values.
Western blot analysis
Protein was extracted from PC12 cells according to the instructions for the protease inhibitor-supplemented M-PER reagent (Pierce, Rockford, IL, USA). The concentration of the extracted proteins was measured using a protein assay reagent kit (BioRad, Hercules, CA, USA). Protein separation was conducted using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the separated proteins were transferred to a nitrocellulose membrane, which was blocked with skim milk powder, for 1 h using the wet-transfer method. Membranes were incubated overnight at 4°C with the following primary antibodies: rabbit polyclonal antibody SHC3 (dilution ratio of 1 : 1000, ab217755), rabbit monoclonal antibody AKT (dilution ratio of 1 : 1000), rabbit monoclonal antibody p-AKT (dilution ratio of 1 : 1000, Ser-473, 8200S), rabbit polyclonal antibody FoxO (dilution ratio of 1 : 2500, ab12162), rabbit polyclonal antibody p-FoxO (dilution ratio of 1 : 500~1 : 1000, Ser-253, ab47285), rabbit polyclonal antibody B-cell lymphoma-2 (Bcl-2) (dilution ratio of 1 : 500~1 : 1000, ab59348), rabbit monoclonal antibody Bax (Bcl-2 Associated X Protein) (dilution ratio of 1 : 1000~1 : 10000, ab32503), rabbit polyclonal antibody Caspase 3 (dilution ratio of 1 : 500, ab13847), rabbit monoclonal antibody Cyclin D1 (dilution ratio of 1 : 10000~1 : 50000, ab134175), rabbit polyclonal antibody Cyclin E (dilution ratio of 1 : 2000, ab71535), and rabbit monoclonal antibody Cyclin A (dilution ratio of 1 : 2000, ab181591). Subsequently, the membranes were rinsed with phosphatebuffered saline-Tween 20 (PBST) three times to remove the primary antibodies and further incubated with the horseradish peroxidase (HRP)-labeled secondary antibody (dilution ratio of 1 : 2000~1 : 10000, goat anti-rabbit antibody, ab6789) at room temperature for 1 h. Next, the membranes were rinsed three times with Tris-buffered saline with Tween (TBST), and proteins were detected with enhanced chemiluminescence (ECL) (Yeasen, Shanghai, China) and visualized in dark conditions. The rabbit monoclonal antibody β-actin (dilution ratio of 1 : 3000, ab8227) was used as the internal reference, and the gray value was analyzed using the ImageJ software. The primary antibodies Akt and p-Akt were purchased from Cell Signaling Technology (Danvers, MA, USA), and the remaining antibodies were purchased from Abcam Inc., (Cambridge, MA, USA). The experimental steps were also used to determine the related protein levels in rat brain tissues.
Statistical analysis
Statistical analyses were performed using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). All experimental procedures were repeated three times. Measurement data were shown as the mean ± standard deviation. Comparisons between two groups were analyzed using the t-test, and comparisons among multiple groups were analyzed with analysis of variance (ANOVA). Differences were considered significant at p < 0.05.
Results
SHC3 silencing hampers rats' body movement
The results of the Rotarod experiment and pole-climbing test are shown in Fig. 1 . In the Rotarod experiment, the duration of time that rats spent on the roller before falling down was significantly longer in the blank group (100.91 ± 10.48 s) than in the model (45.03 ± 7.11 s) and NC groups (40.38 ± 3.75 s) (p < 0.05). The duration of time was significantly shorter in the shRNA group (30.29 ± 2.57 s) than in the model and NC groups (p < 0.05). No significant differences were observed between the model and NC groups (p > 0.05). In the pole-climbing test, the duration of time that the rats needed to move from the top to the bottom of the pole was significantly shorter in the blank group than in the model and NC groups (p < 0.05). The duration of time was significantly longer in the shRNA group than in the model and NC groups (p < 0.05). The NC and model groups exhibited no significant time duration differences (p > 0.05). Therefore, the aforementioned findings suggest that reduced expression of SHC3 causes motor retardation in rats.
SHC3 silencing reduces the numbers of dopamine neurons
The results of TH staining (Fig. 2) demonstrated that there were no evident morphological changes in the midbrain tissues of the blank group, in addition to 
SHC3 silencing exacerbates the OS injury
The levels of the OS indexes SOD, MDA, and GSH are shown in Table 3 . Compared with those in the blank group, the levels of SOD and GSH were significantly decreased, and the MDA level was significantly enhanced in the model, NC and shRNA groups (p < 0.05). No significant differences were observed between the model and NC groups (p > 0.05). Compared with those in the model and NC groups, the shRNA group showed significantly decreased levels of SOD and GSH, and significantly increased levels of MDA (p < 0.05). Therefore, SHC3 was implied to play a protective role in OS injury in PD rats.
SHC3 silencing represses the PI3K-AKT-FoxO signaling pathway in an in vivo experiment
To validate whether shRNA exerts an effect on two isoforms such as p63SHC3 and (Fig. 3A-B) . Furthermore, in order to verify whether SHC3 regulates PD through the PI3K-Akt-FoxO signaling pathway, the mRNA expression and protein levels of PI3K-AktFoxO-related genes in rat brain tissues were evaluated using RT-qPCR and western blot analysis ( Fig. 3C-E ). SHC3 mRNA expression was found to be downregulated in the shRNA group (p < 0.05), while SHC1, SHC2 and SHCD mRNA expression levels showed slight declines in the shRNA group compared with the other three groups (p > 0.05). In contrast to the blank group, the extent of Akt and FoxO phosphorylation was found to be reduced in the other three groups. Compared with the levels observed in the model and NC groups, the shRNA group displayed a decrease in Akt and FoxO phosphorylation (p < 0.05). No significant differences were observed between the NC and model groups (p > 0.05). The results indicate that silenced expression of SHC3 could suppress the PI3K-AKT-FoxO signaling pathway, thereby modulating nigral dopamine neurons in PD rats.
siRNA1 has the highest inhibitory efficiency
After transfection of PC12 cells with liposomes for 48 h, the mRNA expression of SHC3 was detected using RT-qPCR. Compared with that in the blank group, the mRNA expression of SHC3 was significantly lower in the model, NC, siRNA1, siRNA2, and siRNA3 groups (p < 0.05). No significant differences were observed between the model and NC groups (p > 0.05) (Fig. 4A) . The inhibition efficiency in the siRNA1 group was found to be significantly higher than in the siRNA2 and siRNA3 groups (p < 0.05) (Fig. 4B) . Consequently, the siRNA1 group was selected as the siRNA group in subsequent experiments.
SHC3 silencing inhibits cell viability
The result of the MTT assay (Fig. 5) indicated that SHC3 silencing inhibited the growth of PC12 cells. At the 6-h time interval, cell viability was found to be significantly decreased in the model and NC groups compared to that in the blank group (p < 0.05). No significant differences were observed between the model and NC groups (p > 0.05). Compared with that in the model and NC groups, the siRNA group displayed decreased cell activity (p < 0.05). The inhibitory effect of siRNA increased as time went on and peaked at the 24-h time interval. This inhibitory effect demonstrated no significant differences between the model and NC Cell
groups (p > 0.05). The aforementioned findings suggested that silenced expression of SHC3 repressed cell proliferation, which may exacerbate OS injury in nigral dopamine neurons in PD.
G0/G1 phase cells increased, and S/G2 phase cells decreased in the siRNA group
The results of flow cytometry are shown in Fig. 6 . The number of cells in the G0/ G1 phase was increased, and the number of cells in the S/G2 phase was decreased in the model, NC and siRNA groups compared to those the blank group (p < 0.05). No significant differences were observed between the model and NC groups (p > 0.05). Compared with those the model and NC groups, the siRNA group displayed a significantly increased number of cells in the G0/G1 phase and a significantly decreased number of cells in the S/G2 phase (p < 0.05), suggesting that some neurons re-entered into the cell cycle and that cells were arrested in the G0/G1 phase by SHC3 silencing. RT-qPCR and western blot analysis showed that the levels of cell cycle-related genes Cyclin D1, Cyclin E, and Cyclin A were lower in the model, siRNA and NC groups than in the blank group (p < 0.05). Compared with the model and NC groups, the siRNA group exhibited lower levels of Cyclin D1, Cyclin E, and Cyclin A (p < 0.05). The model and NC groups displayed no significant differences (p > 0.05). These findings indicated that silenced expression of SHC3 suppressed cell cycle progression, which may exacerbate OS injury in nigral dopamine neurons in PD.
SHC3 silencing increases cell apoptosis
The results of PI double staining (Fig. 7) demonstrate that cell apoptosis was elevated in the siRNA group compared to that in the blank and model groups (p < 0.05), indicating that SHC3 inhibited cell apoptosis in dopaminergic neurons in PD. RT-qPCR and western blot analysis displayed that levels of Bcl-2 were reduced, and levels of Bax and Caspase 3 were found to be enhanced in the model, NC, and siRNA groups compared to those of the blank group (p < 0.05). No significant differences were found between the model and NC groups (p > 0.05). Compared with the model and NC groups, the siRNA group exhibited decreased levels of Bcl-2, in addition to increased levels of Bax and Caspase 3, suggesting that SHC3 silencing promoted cell apoptosis in dopaminergic neurons via regulation of Bcl-2, Bax, and Caspase 3. The aforementioned findings suggested that lower expression of SHC3 induced cell apoptosis and consequently aggravated OS injury in nigral dopamine neurons in PD.
SHC3 silencing represses the PI3K-AKT-FoxO signaling pathway
The results of RT-qPCR and western blot analysis are shown in Fig. 8 . A polyclonal antibody was used to detect the two isoforms, p63SHC3 and p52SHC3, through western blot analysis. The protein levels of p63SHC3 and p52SHC3 were found to be reduced in the siRNA group compared with those in the model, NC, and blank groups (p < 0.05), suggesting that the protein levels of the two isoforms of SHC3, p63SHC3 and p52SHC3, were suppressed in response to siRNA. There were no significant differences in levels of AKT and FoxO among the four groups, whereas the extent of AKT and FoxO phosphorylation was found to be significantly lower in the model, NC, and siRNA groups than in the blank group (p < 0.05). Compared with that in the model and NC groups, the siRNA group displayed a reduced level of AKT and FoxO phosphorylation (p < 0.05). The model and NC groups displayed no significant difference (p > 0.05). The above results revealed that SHC3 silencing may repress the PI3K-AKT-FoxO signaling pathway and protect nigral dopamine neurons from degenerative changes in PD rats.
Discussion
Parkinson's disease (PD), as the second most prevalent degenerative disorder of the central nervous system, currently affects more than 100, 000 individuals worldwide [22] [23] [24] . Despite extensive preclinical studies in PD animal models, there is still a lack of effective neuroprotective drugs for PD available [25, 26] . Interestingly, the P13K-AKT-FoxO signaling pathway has been suggested to be implicated in the treatment of PD [27] . The current study suggests that SHC3 silencing inhibits the PI3K-AKT-FoxO signaling pathway and consequently exacerbates OS injury in nigral dopamine neurons in PD rats.
The findings of the current study revealed that SHC3 shRNA treatment may decrease SOD and MDA and enhance the activity of GSH. SOD is verified to be overexpressed to antagonize the oxidative burden [28] . A previous study demonstrated that high levels of SOD1 decreased OS and further alleviated neuronal injury from cerebral ischemia [29] . MDA is considered an OS biomarker and is expressed in the process of oxidative degradation of polyunsaturated lipids [30] . MDA levels have also been found to be downregulated after treatment in patients with hypothyroidism, which is a state of enhanced OS [31] . It was previously demonstrated that reduced GSH status signifies an increased level of OS [32] . Another study demonstrated that primary cultures of cortical neurons from SHC3 null mice are more sensitive to hypoxia/ oxidative-induced apoptosis owing to positive regulation of the PI3K-AKT signaling pathway [33] , and decreased levels of SHC3 contribute to the enhanced vulnerability of the aged brain to OS [34] . From the aforementioned evidence, SHC3 silencing was shown to be associated with increased OS injury in nigral dopamine neurons.
Additionally, the current study demonstrated that in PC12 cells, SHC3 siRNA treatment decelerated cell proliferation, accelerated G1/G0 phase cells, decreased S/G2 phase cells, and enhanced cell apoptosis. SHC3 is a phosphotyrosine-binding domain-containing adaptor protein that signals to cellular differentiation and survival pathways, for example, the AKT signaling pathway [35] . It was previously revealed that SHC3 overexpression promotes neuronal cell survival and inhibits apoptosis by activating the PI3K-AKT signaling pathway [36] . A previous study showed that expression of p52SHC3, a truncated variant of SHC3, leads to reduced AKT phosphorylation and enhanced apoptosis in vitro [37] . Previous studies have demonstrated that reduced levels of Cyclin D1 were correlated with decreased protein levels and decreased phosphorylation levels of PI3K-AKT and that inhibition of PI3K coordinately reduces Cyclin E protein levels [38, 39] . Moreover, Cyclin A1 was reported to be a crucial downstream target of the PI3K/AKT signaling pathway, which conveys survival signals in response to IL6 stimulation [40] . As a member of the Bcl-2 family, Bax is a type of nuclear-encoded protein that is expressed in higher eukaryotes and is able to pierce the outer membrane of mitochondria to mediate cell death through apoptosis [41] . Inhibition of the PI3K-AKT signaling pathway has been demonstrated to be correlated with reduced levels of anti-apoptotic Bcl-2 and increased levels of pro-apoptotic Bax, subsequently leading to cell apoptosis [42, 43] . Caspase 3, a frequently activated mediator of programmed apoptosis, is known to catalyze the cleavage of numerous key cellular proteins, such as TG2 and Atg7 KD [44] . A previous study demonstrated that downregulation of AKT phosphorylation following Caspase 3 activation has the ability to inhibit generalized cellular proliferation and induce apoptosis [45] .
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In addition, the current study demonstrated that cells transfected with SHC3 siRNA exhibited reduced levels of AKT and FoxO phosphorylation. The reduced expression of SHC3 could suppress the activation of the PI3K-AKT-FoxO signaling pathway, thereby modulating nigral dopamine neurons in PD rats. A previous study found that decreased AKT expression was associated with reduced dopaminergic neurons in PD, and furthermore, the activation of AKT is linked to the abundance of dopaminergic neurons, offering neuroprotection in PD [46] . In addition, another study found that FoxO proteins modulated gene expression involved in oxidative stress and were regulated by AKT [47] . Interestingly, the stress response factor FoxO3, a member of the FoxO family, was considered neuroprotective in PD by another study [48] . Moreover, SHC3 was found to positively affect neural cell survival through decreased Akt phosphorylation [37] . Therefore, the aforementioned findings demonstrate that the PI3K-AKT-FoxO signaling pathway was downregulated via SHC3 silencing in nigral dopamine neurons in PD rats.
In summary, the current study demonstrates that SHC3 silencing aggravates OS injury in nigral dopamine neurons via downregulation of the PI3K-AKT-FoxO signaling pathway in PD rats. These findings provide a potential mechanism for the further understanding and treatment of PD. However, further exploration of the mediation between SHC3 and the PI3K-AKT-FoxO signaling pathway is warranted in order to better understand the precise molecular regulation.
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